Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 23

Trial Status

Completed2
Other2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT00919555Phase 1/2Completed
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Principalinvestigator
NCT01259050Phase 1/2Completed
Safety Study of High Doses of Zinc in ALS Patients
Amyotrophic Lateral Sclerosis
Principalinvestigator
Dermatomyositis and Polymyositis Registry
DermatomyositisPolymyositis
Principalinvestigator
NCT01835782Phase 1/2Unknown
Determining the Safety of L-serine in ALS
Amyotrophic Lateral Sclerosis (ALS)
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Phoenix Neurological Associates, LTD

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Petros Efthimiou, MD

New York Presbyterian Brooklyn Methodist Hospital

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

Phoenix Neurological Associates, LTD
Collaborated on 1 trial
Similarity Score24%

Rup Tandan, MD

University of Vermont

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

Phoenix Neurological Associates, LTD
Collaborated on 1 trial
Similarity Score24%

Justine Malone, MD

Neurology INC

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

Phoenix Neurological Associates, LTD
Collaborated on 1 trial
Similarity Score24%

Ara Dikranian, MD

Ara Dikranian MD

Related
1 trials

Shared therapeutic areas:

DermatomyositisPolymyositis

Worked with same sponsors:

Phoenix Neurological Associates, LTD
Collaborated on 1 trial
Similarity Score24%

Carl Pepine, MD

University of Florida

Related
7 trials

Shared therapeutic areas:

DermatomyositisPolymyositis
Similarity Score20%

David S Saperstein, MD

Phoenix Neurological Associates, LTD

Related
1 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis

Worked with same sponsors:

Phoenix Neurological Associates, LTD
Collaborated on 1 trial
Similarity Score14%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Jane Huggins, PhD

University of Michigan

Related
6 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Amyotrophic Lateral Sclerosis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00919555Phase 1/2PrincipalInvestigator

Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis
Completed
NCT01259050Phase 1/2PrincipalInvestigator

Safety Study of High Doses of Zinc in ALS Patients

Amyotrophic Lateral Sclerosis
Completed
NCT01637064PrincipalInvestigator

Dermatomyositis and Polymyositis Registry

DermatomyositisPolymyositis
Unknown
NCT01835782Phase 1/2PrincipalInvestigator

Determining the Safety of L-serine in ALS

Amyotrophic Lateral Sclerosis (ALS)
Unknown

All 4 trials loaded